Outcomes
The primary outcome was all-cause mortality among hospitalized patients
(inpatient encounters) with SARS-CoV2 infection. We also evaluated
intensive care unit (ICU) admission and AKI among hospitalized patients.
Further, we examined hospitalization among all encounters (inpatient and
outpatient). The primary analysis compared outcomes between patients
with a history of cancer to those without a history of cancer. Secondary
analyses compared outcomes between patients with specific neoplasm
locations (kidney, prostate, bladder, lung, hematological, general
genitourinary). Oncologic co-morbidities were determined by ICD-10 codes
in patients’ problem lists in the EMR. Patients were included in the
specific neoplasm location cohorts regardless of whether the ICD-10
noted the neoplasm as primary, secondary, or unspecified.